Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

How to access Pharma in Focus articles
  • If you're a current subscriber, See below

  • If you're new to Pharma in Focus, Click here

  • If you haven't SUBSCRIBED yet, Click here

Current Subscribers

If you are are current Full Text Subscriber or have taken out a Free Trial, please type your email address into the form below.

This will restore your access and return you to the Home Page.

Email Address
 
Pipeline Monitor
AZ's lung cancer victory
Checkpoint inhibitor Imfinzi beats the competition to indication for inoperable disease.
Perspective
This is what courage looks like
One pharmaco has shown the courage to empower a much-needed conversation about change.
Approvals Action
New delivery device for top biologic
TGA says Roche can market an updated method for injecting top-selling bDMARD.